FindTrial
Sign In

A clinical interventional study to compare the efficacy of two combined non invasive brain stimulation as motor enhancement therapy for upper extremity in brain attack due to blocked blood vessel cases of more than six months.

A randomized controlled trial to compare the efficacy of coupled transcranial stimulation with decoupled transcranial stimulation and sham stimulation as motor enhancement therapy for upper extremity in chronic ischemic stroke cases

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/11/022009
Enrollment
112
Registered
2019-11-14
Start date
Unknown
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I633- Cerebral infarction due to thrombosis of cerebral arteries

Interventions

Intervention1: Coupled non invasive brain stimulation (real tDCS with real rTMS) : Decoupled non invasive brain stimulation (Real tDCS + Sham rTMS, Sham tDCS + real rTMS, Sham rTMS + Sham tDCS) Inter

Sponsors

JIPMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Age between 18year and 70year b) Cases diagnosed as stroke by MRI/CT scan as non-recurrent chronic MCA ischemic stroke c) Cases after six months of post stroke d) Normal as per Montreal Cognitive Assessment e) Brunnstrom 3-5 stages of recovery R

Exclusion criteria

Exclusion criteria: a) Any contraindications for rTMS/tDCS intervention. b) Any other associated neuropsychiatric disorder c) Underwent any prior non-invasive brain stimulation

Design outcomes

Primary

MeasureTime frame
Fugl-Meyer Assessment - Upper extremityTimepoint: Baseline, After 10 sessions of treatment, 12 weeks—

Secondary

MeasureTime frame
Modified Modified Ashworth Scale(MMAS), Somatosensory evoked potential(SSEP), Single Photon Emission Computed Tomography(SPECT), Modified Rankin Scale(mRS) and Stroke Specific Quality of Life Scale (SS-QOL)Timepoint: Baseline, After 10 sessions of treatment, 12 weeks—

Countries

India

Contacts

Public ContactJeshma Jayan

JIPMER, Pondicherry

jeshmajayan07@gmail.com04132297447

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Apr 4, 2026